Indaptus Therapeutics Entered Stock Sale Agreement To Sell 20M Shares For $0.06/Share; Gross Proceeds Of $12M

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001857044/000149315226029918/form8-k.htm

Comments

No comments yet. Be the first!